18
Dec

Roche is betting big on antibodies that can attack two targets at once, signing on to buy Austria’s Dutalys for as much as $488.8 million and get its hands on some proprietary technology.

…read more

Source: Roche boosts its antibody arsenal with a $489M buyout

    

0 No comments